An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain

NCT00089557 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Herpes Zoster
Neuralgia
Pain
HIV Infections
Peripheral Nervous System Diseases
Diabetic Neuropathies
Diabetes Mellitus
Polyneuropathies

Interventions

DRUG: Capsaicin Dermal Patch

Sponsor

NeurogesX